Progyny, Inc. - Common Stock (NQ:PGNY)

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other...

Topics Economy

November 21, 2025

A Look Back at Health Insurance Providers Stocks’ Q3 Earnings: Progyny (NASDAQ:PGNY) Vs The Rest Of The Pack

November 17, 2025

Let’s dig into the relative performance of Progyny (NASDAQ:PGNY) and its peers as we unravel the now-completed Q3 health insurance providers earnings season.

New Men’s Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action

Topics Artificial Intelligence Economy Fraud

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

November 20, 2025

75% of men see fertility as an equal gender topic and acknowledge the connection between fertility health and their overall health, yet only 46% of men with a fertility issue have sought support due to...

Progyny’s third quarter was marked by strong top-line and profitability outperformance, which drew a positive market response. Management attributed these results to robust new client acquisition, the...

5 Must-Read Analyst Questions From Progyny’s Q3 Earnings Call

November 13, 2025

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial...

Topics Earnings Workforce

3 Inflated Stocks with Warning Signs

November 12, 2025

Progyny generates nearly $200 million in free cash flow annually and holds over $300 million in cash, yet it has a market cap of only $1.9 billion. It could be a bargain as stock-based compensation...

This AT&T Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday ↗

November 12, 2025

Via Benzinga

Why Progyny Stock Is Soaring Today ↗

November 07, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 07, 2025

Via Benzinga

PGNY Q3 Deep Dive: Product Expansion and Client Diversification Drive Momentum

November 07, 2025

Fertility benefits company Progyny (NASDAQ:PGNY) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 9.3% year on year to $313.3 million. Revenue guidance for the full...

PROGYNY INC (NASDAQ:PGNY) Q3 2025 Earnings Beat Estimates and Boost Full-Year Outlook ↗

November 06, 2025

Progyny (PGNY) Q3 2025 earnings beat estimates with $313.3M in revenue and $0.45 EPS. The company raised its full-year guidance, driving a positive market reaction.

Via Chartmill

Topics Earnings

Progyny (NASDAQ:PGNY) Reports Upbeat Q3, Stock Soars

November 06, 2025

Fertility benefits company Progyny (NASDAQ:PGNY) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 9.3% year on year to $313.3 million. Revenue guidance for the full...

Progyny, Inc. Announces Third Quarter 2025 Results

November 06, 2025

Progyny (PGNY) Q3 Earnings: What To Expect

November 04, 2025

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because...

Topics Artificial Intelligence

3 of Wall Street’s Favorite Stocks We Find Risky

November 02, 2025

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

3 Small-Cap Stocks with Warning Signs

October 27, 2025

Progyny, Inc. Announces Details for Its Third Quarter 2025 Results Report

October 23, 2025

Motley Fool analysts Karl Thiel, Rick Munarriz, and Tim Beyers offer up three stocks that face dark clouds they can see through.

Checking In on The Trade Desk, Bristol Myers Squibb, and Other Stocks ↗

October 22, 2025

Via The Motley Fool

Topics Workforce

Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause

October 22, 2025

Global employers can now empower their workforces with comprehensive women’s health benefits, supported by localized expertise

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

1 Safe-and-Steady Stock with Exciting Potential and 2 We Question

October 22, 2025

A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining...

Topics Supply Chain

1 Cash-Heavy Stock to Target This Week and 2 That Underwhelm

October 20, 2025

Progyny Stock Logs Best Day In 2 Months As BofA Calls Trump IVF Policy ‘Incremental Positive’ — Traders Eye More Upside ↗

October 16, 2025

Trump may potentially announce new measures to expand access to in-vitro fertilization, including guidance for employers to offer supplemental fertility insurance and steep discounts on key IVF drugs.

Via Stocktwits

Topics Government World Trade

3 Stocks Under $50 with Questionable Fundamentals

October 07, 2025

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some...

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

3 Cash-Producing Stocks We Think Twice About

October 06, 2025

Federal Reserve Signals Further Rate Cuts Amidst Worsening Labor Market and Divided Opinions

October 14, 2025

Washington D.C. – The Federal Reserve has sent clear signals of a continued dovish pivot, with Chair Jerome Powell indicating the likelihood of two additional quarter-point interest rate cuts before...

Via MarketMinute

Topics Artificial Intelligence Bonds Credit Cards

3 Reasons to Avoid PGNY and 1 Stock to Buy Instead

October 02, 2025

Over the past six months, Progyny’s shares (currently trading at $20.90) have posted a disappointing 9.1% loss, well below the S&P 500’s 18.4% gain. This might have investors contemplating their next...

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of...

Topics Stocks Supply Chain

1 Healthcare Stock with Exciting Potential and 2 We Question

September 30, 2025

Motley Fool analysts take a look.

Topics Stocks

A Healthcare Debate: Progyny vs. Hims & Hers ↗

September 26, 2025

Via The Motley Fool

Health Insurance Providers Stocks Q2 Results: Benchmarking Progyny (NASDAQ:PGNY)

September 15, 2025

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the health insurance providers stocks, including Progyny (NASDAQ:PGNY) and its peers.